CCK peptides with combined features of hexa- and tetrapeptide CCK-A agonists

Journal of Medicinal Chemistry

Volumn 43, Issue 12, 2000, Pages 2350-2355

  Pierson, M Edward ^a   Comstock, Jeanne M ^a   Simmons, Roy D ^a   Julien, Ronald ^a   Kaiser, Frederick ^a   Rosamond, James D ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ RECEPTOR STIMULATING AGENT; HEXAPEPTIDE; TETRAPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; FOOD INTAKE; MALE; NONHUMAN; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STRUCTURE ACTIVITY RELATION; WEIGHT REDUCTION;

ANIMALS; APPETITE DEPRESSANTS; BINDING, COMPETITIVE; BODY WEIGHT; CEREBRAL CORTEX; EATING; MALE; OLIGOPEPTIDES; PANCREAS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CHOLECYSTOKININ A; RECEPTORS, CHOLECYSTOKININ; STRUCTURE-ACTIVITY RELATIONSHIP; SYNAPTOSOMES;

EID: 0033919839     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm990252e     Document Type: Article

References (25)

1. Mutt, V. Cholecystokinin: Isolation, Structure and Functions. In Gastrointestinal Hormones; Glass. G. B. J., Ed.; Raven Press: New York, 1980; pp 169-221.
2. Vanderhaeghen, J. J.; Crawley, J., N. Neuronal Cholecystokinin. Ann. N.Y. Acad. Sci. 1985, 448.
3. Crawley, J. N.; Corwin, R. L. Biological Actions of Cholecystokinin. Peptides 1994, 15, 731-755.
4. Dourish, C., T.; Hill, D. R. Classification and Function of CCK Receptors. Trends Pharmacol. Sci. 1987, 8, 207-208.
5. Smith, G. P.; Gibbs, J. Satiating Effect of Cholecystokinin. Ann. N.Y. Acad. Sci. 1994, 773, 236-241.
6. Pierson, M. E.; Comstock, J.; Simmons, R. D.; Kaiser, F. C.; Julien, R. P.; Zongrone, J.; Rosamond. J. D. Synthesis and Biological Evaluation of Potent, Selective Hexapeptide CCK-A Agonist Anorectic Agents. J. Med. Chem. 1997, 40, 4302-4307.
7. Lin, C.; Holladay, M. W.; Witte, D.; Miller. T.; Wolfram, C.; Bianchi, B. R.; Bennett, M.; Nadzan, A. A71378: A CCK Agonist with High Potency and Selectivity for CCK-A Receptors. Am. J. Physiol. 1990, 258, G648-651.
8. Holladay, M. W.; Bennett, M.; Tufano, M.; Lin, C.; Asin, K.; Witte, D.; Miller, T.; Bianchi, B.; Bednarz, L.; Nadzan, A. Synthesis and Biological Activities of CCK Heptapeptide Analogues. Effects on Conformational Constraints and Standard Modifications on Receptor Subtype Selectivity and Functional Activity in Vitro and Appetite Suppression In Vivo. J. Med. Chem. 1992, 35, 2919-2928.
9. Nadzan, A. M.; Kerwin, Jr., J. F. Cholecystokinin Agonists and Antagonists. In Annual Reports in Medicinal Chemistry, Bristol, J. A., Ed., Academic: San Diego, CA, 1991; pp 191-200.
10. Shiosaki, K.; Lin, C. W.; Kopecka, H.; Tufano, M. D.; Bianchi, B. R.; Miller, T. R.; Witte, D. G.; Nadzan, A. M. Boc-CCK-4 Derivatives Containing Side-Chain Ureas as Potent and Selective CCK-A Receptor Agonist. J. Med. Chem. 1991, 34, 2837-2842.
11. Aquino, C.; Armour, D.; Berman, J.; Birkemo, L.; Carr, R.; Croom, D.; Dezube, M.; Dougherty, R.; Ervin, G.; Grizzle, M.; Head, J.; Hirst, G.; James, M.; Johnson, M.; Miller, L.; Queen, K.; Rimele, T.; Smith, D.; Sugg, E. Discovery of 1,5-Benzodiazepines with Peripheral Cholecystokinin (CCK-A) Receptor Agonist Activity. 1. Optimization of the Agonist "Trigger". J. Med. Chem. 1996, 39, 562-569.
12. Bignon, E.; Bachy, A.; Boigegrain, R.; Brodin, R.; Cottineau, M.; Gully, D.; Hebert, J.-M.; Keane, P.; Labie, C.; Molimard, J.-C.; Olliero, D.; Oury-Donat, F.; Petereau, C.; Prabonnaud, V.; Rockstroh, M.-P.; Schaeffer, P.; Servant, O.; Thurneyssen, O.; Soubrie, P.; Pascal, M.; Maffrand, J.-P.; Le Fur, G. SR146131: A New Potent, Orally Active, and Selective Nonpeptide Cholecystokinin Subtype 1 Receptor Agonist. I: In Vitro Studies. J. Pharmacol. Exp. Ther. 1999, 289, 742-751.
13. Bignon, E.; Alonso, R.; Arnone, M.; Boigegrain, R.; Brodin, R.; Gueudet, C.; Héaulme, M.; Keane, P.; Landi, M.; Molimard, J.-C.; Olliero, D.; Poncelet, M.; Seban, E.; Simiand, J.; Soubrie, P.; Pascal, M.; Maffrand, J.-P.; Le Fur, G. SR146131: A New Potent, Orally Active, and Selective Nonpeptide Cholecystokinin Subtype 1 Receptor Agonist. II: In Vivo Pharmacological Characterization. J. Pharmacol Exp. Ther. 1999, 289, 752-761.
14. Shiosaki, K.; Lin, C. W.; Kopecka, H.; Craig, R.; Bianchi, B.; Miller, T.; Witte, D.; Stashko, M.; Nadzan, A. Development of Potent and Selective CCK-A Receptor Agonist from Boc-CCK-4: Tetrapeptides Containing Lys(N′)-Amide Residues. J. Med. Chem. 1992, 35, 2007-2014.
15. Holladay, M.; Kopecka, H.; Miller, T.; Bednarz, L.; Nikkel, A.; Bianchi, B.; Witte, D.; Shiosaki, K.; Lin, C. W.; Asin, K.; Nadzan, A. Tetrapeptide CCK-A Agonists: Effect of Backbone N-Methylation on in Vitro and in Vivo CCK Activity. J. Med. Chem. 1994, 37, 630-635.
16. Albericio, F.; Kneib-Cordonier, N.; Lajos, G.; Hammer, R.; Hudson, D.; Barney, G. Solid-Phase Synthesis of C-terminal Peptide Amides Under Mild Conditions. In Peptides Chemistry and Biology, Proceedings of the Tenth American Peptide Symposium; Marshall, G. R., Ed; Escom: Leiden, 1988; pp 159-161.
17. King, D. S.; Fields, C. G.; Fields, G. B. A Cleavage Method Which Minimizes Side Reactions Following Fmoc Solid-Phase Peptide Synthesis. Int. J. Pept. Protein Res. 1990, 36, 255-266.
18. 3H-(±)-L-364,718: A New Potent, Nonpeptide Cholecystokinin Antagonist Radioligand Selective for Peripheral Receptors. Mol. Pharmacol. 1986, 30, 212-217.
19. Chang, R. S. L.; Lotti, V. J. Biochemical and Pharmacological Characterization of an Extremely Potent and Selective Nonpeptide Cholecystokinin Antagonist. Proc. Natl. Acad. Sci. U.S.A. 1986, 83, 4923-4926.
20. Cox, R. H.; Maickel, R. P. Comparison of Anorexigenic and Behavioral Potency of Phenylethylamines. J. Pharmacol. Exp. Ther. 1972, 181, 1-9.
21. Asin, K.; Bendnarz, L.; Nikkel, A.; Gore, P.; Nadzan, A. A-71623, A Selective CCK-A Receptor Agonist, Suppresses Food Intake in the Mouse, Dog and Monkey. Pharmacol. Biochem. Behav. 1992, 42, 699-704.
22. Peptide nomenclature follows the guidelines of the IUPAC-IUB Joint Commission on Biochemical Nomenclature. Eur. J. Biochem. 1984, 138, 9-37.
23. 50) of an Enzyme Reaction. Biochem. Pharmacol. 1973, 22, 3099-3108.
24. Linden, J. Calculating the Dissociation Constant of an Unlabeled Compound from the Concentration Required to Displace Radiolabel Binding by 50%. J. Cyc. Nucleotide Res. 1982, 8, 162-172.
25. Feldman, H. A. Mathematical Theory of Complex Ligand-Binding Systems at Equilibrium: Some Methods of Parameter Fitting. Anal. Biochem. 1972, 48, 317-338.